NCPDP Foundation Announces FDB as its Inaugural Patient Safety Founders Gift Donor

[Margaret Kelly]

NCPDP Foundation Announces FDB as its Inaugural Patient Safety Founders Gift Donor to Advance Research Priorities

Robert C. Katter, FDB President, to Serve as Patient Safety Chair for the Foundation’s Newly Established National Advisory Council

SCOTTSDALE, ARIZ. MARCH 29, 2022--The NCPDP Foundation today announced FDB (First Databank, Inc.) as its inaugural Patient Safety Founders Gift Donor. FDB’s donation of $100,000 will support future research projects over the next two years that demonstrate and measure one or more existing or future NCPDP standards that align with the Foundation’s strategic initiative to enhance patient safety. FDB President Robert C. (“Bob”) Katter will serve as the NCPDP Foundation’s National Advisory Council (NAC) Chair for Patient Safety.

The NCPDP Foundation’s newly established NAC will focus its fundraising efforts in support of three research priorities: enhance patient safety; expand access to care; and expand the role and value of pharmacists. The NAC is composed of volunteer leaders who are committed to advancing NCPDP and its national initiatives. Members represent the highest levels of industry, philanthropy and non-governmental organizations and serve in an advisory rather than fiduciary role.

“We are honored that FDB has recognized the need to support future research projects that demonstrate the value of NCPDP standards that enhance patient safety. FDB is aligned with the NCPDP Foundation in working to enable healthcare providers to electronically access and share timely, accurate information to help prevent medication errors,” said J.W. Hill, MBAHCM, CNED, Executive Director, NCPDP Foundation.

Lee Ann Stember, NCPDP’s President & CEO and NCPDP Foundation Board Member, stated, “We value the long-standing commitment of FDB to NCPDP − and now to the NCPDP Foundation. The donation provided by FDB will further our ability to expand on patient safety research projects, such as the CancelRx Projects, that support NCPDP in leading the industry in healthcare standards and solutions for the common good.”

Since joining FDB in 2010, Bob Katter has played a central role in growing the company to become a proven leader in medication decision support.

“I am honored to serve as patient safety chair for the NCPDP Foundation’s new National Advisory Council and for FDB to be part of the NCPDP Foundation’s important research,” said Katter. “FDB’s decades-long collaboration with NCPDP has enabled us to more effectively deliver drug knowledge within the workflows of healthcare professionals throughout every segment of the industry. This new endeavor further supports our mission to enhance medication-related decisions and, ultimately, help eliminate medication errors and reduce adverse drug events.”